Daratumumab Demonstrates Benefit to Overall Survival for Certain Patients with Multiple Myeloma
June 16th 2021The addition of daratumumab to lenalidomide and dexamethasone resulted in a significant benefit to overall survival in patients with newly diagnosed multiple myeloma who were ineligible for autologous stem cell transplant and were treated to progression, according to the results of the phase 3 MAIA study.
Read More
The Multiple Myeloma Treatment Pipeline and Specialty Pharmacy
June 15th 2021Dealing with a cancer diagnosis is difficult, but patients with MM have reason to be hopeful. Survival rates are on the rise, and a robust pipeline of promising immunotherapies and novel treatment options are in development.
Read More
Assessing How Increases in COVID-19 Vaccine Prices May Impact Pharmacies
June 14th 2021Susan Lang, MA, MBA, the CEO of XIL Health, discusses how pharmacies that have already been hard hit by the pandemic may be impacted if Pfizer goes through with their projected increased in COVID-19 vaccine prices.
Watch
Report Finds ‘Uphill Battle’ For Pharmacists Combatting COVID-19 Vaccine Hesitancy
June 14th 2021Although the United States has surpassed the milestone of 100 million COVID-19 vaccinations, a study found that reaching 200 million will be significantly more challenging as vaccine hesitancy remains.
Read More